Abstract:Ecumicins are potent antituberculosis natural compounds produced by the rare actinomycete Nonomuraea sp. MJM5123. Here, we report an efficient genetic manipulation platform of this rare actinomycete. CRISPR/Cas9-based genome editing was achieved based on successful sporulation. Two genes in the ecumicin gene cluster were further investigated, ecuN and ecuE, which potentially encode a pretailoring cytochrome P450 hydroxylase and the core peptide synthase, respectively. Deletion of ecuN led to an enhanced ratio of the ecumicin compound EcuH16 relative to that of EcuH14, indicating that EcuN is indeed a P450 hydroxylase, and there is catalyzed hydroxylation at the C-3 position in unit12 phenylalanine to transform EcuH16 to the compound EcuH14. Furthermore, promoter engineering of ecuE by employing the strong promoter kasO*P was performed and optimized. We found that integrating the endogenous ribosome-binding site (RBS) of ecuE together with the RBS from kasO*P led to improved ecumicin production and resulted in a remarkably high EcuH16/EcuH14 ratio. Importantly, production of the more active component EcuH16 was considerably increased in the double RBSs engineered strain EPR1 compared to that in the wild-type strain, reaching 310 mg/L. At the same time, this production level was 2.3 times higher than that of the control strain EPA1 with only one RBS from kasO*P. To the best of our knowledge, this is the first report of genome editing and promoter engineering on the rare actinomycete Nonomuraea.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acssynbio.0c00248?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acssynbio.0c00248</a>.Biosynthetic gene clusters of the antibiotic and secondary metabolites in Nonomuraea sp. MJM5123 (PDF), bacterial strains used in this study, oligonucleotides used in this study, genome-scale phylogenetic tree of Nonomuraea sp. MJM5123 and its closely related species, combination strategy of spore-conjugation and CRISPR/Cas9 technology in Nonomuraea sp. MJM5123, gene disruption and complementation of ecuN in wild-type Nonomuraea sp. MJM5123, construction of the ΔNRPS mutants by using one plasmid CRISPR/Cas9-CodA(sm)-combined system, and construction of the promoter-engineering mutants by using one plasmid CRISPR/Cas9-CodA(sm)-combined system (<a class="ext-link" href="/doi/suppl/10.1021/acssynbio.0c00248/suppl_file/sb0c00248_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Draft genome sequence of Actinomadura sp. K4S16 and elucidation of the nonthmicin biosynthetic pathway

Identification of the Actinomycin D Biosynthetic Pathway from Marine-Derived Streptomyces costaricanus SCSIO ZS0073

Genomics-driven Discovery of the Biosynthetic Gene Cluster of Maduramicin and Its Overproduction in Actinomadura Sp. J1-007

The Biosynthetic Gene Cluster of the Maytansinoid Antitumor Agent Ansamitocin from Actinosynnema Pretiosum

The biosynthetic pathway to tetromadurin (SF2487/A80577), a polyether tetronate antibiotic

Identification of the Biosynthetic Gene Cluster of Thermoactinoamides and Discovery of New Congeners by Integrated Genome Mining and MS-Based Molecular Networking

Genomic Analysis of Kitasatospora setae to Explore Its Biosynthetic Potential Regarding Secondary Metabolites

Reconstitution Of Kinamycin Biosynthesis Within The Heterologous Host Streptomyces Albus J1074

Enhanced Production of Active Ecumicin Component with Higher Antituberculosis Activity by the Rare Actinomycete Nonomuraea sp. MJM5123 Using a Novel Promoter-Engineering Strategy

Description of Streptomyces naphthomycinicus sp. nov., an endophytic actinobacterium producing naphthomycin A and its genome insight for discovering bioactive compounds

Cloning And Functional Analysis Of The Naphthomycin Biosynthetic Gene Cluster In Streptomyces Sp Cs

Genome assembly, comparative genomics, and identification of genes/pathways underlying plant growth-promoting traits of an actinobacterial strain, Amycolatopsis sp. (BCA-696)

Genome-guided and mass spectrometry investigation of natural products produced by a potential new actinobacterial strain isolated from a mangrove ecosystem in Futian, Shenzhen, China

Exploring the Potential of Antibiotic Production From Rare Actinobacteria by Whole-Genome Sequencing and Guided MS/MS Analysis

Coordinated Biosynthesis of the Purine Nucleoside Antibiotics Aristeromycin and Coformycin in Actinomycetes

Genome-guided Investigation of Antibiotic Substances Produced by Allosalinactinospora Lopnorensis CA15-2T from Lop nor Region, China

Genome sequence of Micromonospora terminaliae TMS7T, a new endophytic actinobacterium isolated from the medicinal plant Terminalia mucronata.

Draft Genome Sequence of an Efficient Antibiotic-Producing Industrial Strain of Saccharomonospora azurea, SZMC 14600

Secondary metabolites from the Actinomadura sp. and their cytotoxic activity

Deciphering pactamycin biosynthesis and engineered production of new pactamycin analogues

Characterization of inthomycin biosynthetic gene cluster revealing new insights into carboxamide formation